276 related articles for article (PubMed ID: 33541282)
21. Logarithmic expansion of LGR5
Martin ML; Zeng Z; Adileh M; Jacobo A; Li C; Vakiani E; Hua G; Zhang L; Haimovitz-Friedman A; Fuks Z; Kolesnick R; Paty PB
Cell Signal; 2018 Jan; 42():97-105. PubMed ID: 28958617
[TBL] [Abstract][Full Text] [Related]
22. MUC1-C drives stemness in progression of colitis to colorectal cancer.
Li W; Zhang N; Jin C; Long MD; Rajabi H; Yasumizu Y; Fushimi A; Yamashita N; Hagiwara M; Zheng R; Wang J; Kui L; Singh H; Kharbanda S; Hu Q; Liu S; Kufe D
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427590
[TBL] [Abstract][Full Text] [Related]
23. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
24. In situ validation of an intestinal stem cell signature in colorectal cancer.
Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
[TBL] [Abstract][Full Text] [Related]
25. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
[TBL] [Abstract][Full Text] [Related]
26. Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia.
Harpaz N; Taboada S; Ko HM; Yu J; Yang Q; Xu H; Cao W
Inflamm Bowel Dis; 2014 Apr; 20(4):703-11. PubMed ID: 24518605
[TBL] [Abstract][Full Text] [Related]
27. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
Ma C; Henn P; Miller C; Herbst C; Hartman DJ; Pai RK
Am J Surg Pathol; 2019 Oct; 43(10):1314-1322. PubMed ID: 31318711
[TBL] [Abstract][Full Text] [Related]
28. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Ota H; Tanaka E
Ann Diagn Pathol; 2020 Oct; 48():151587. PubMed ID: 32829068
[TBL] [Abstract][Full Text] [Related]
29. Chronic ulcerative colitis and colorectal cancer.
Rogler G
Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
[TBL] [Abstract][Full Text] [Related]
31. Role of Lgr5-positive cells in colorectal cancer.
Ding H; Wang C
Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
33. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence.
Beitia M; Solano-Iturri JD; Errarte P; Sanz B; Perez I; Etxezarraga MC; Loizate A; Asumendi A; Larrinaga G
Int J Med Sci; 2019; 16(6):813-821. PubMed ID: 31337954
[No Abstract] [Full Text] [Related]
35. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
36. Characterization of chromosomal instability in murine colitis-associated colorectal cancer.
Gerling M; Glauben R; Habermann JK; Kühl AA; Loddenkemper C; Lehr HA; Zeitz M; Siegmund B
PLoS One; 2011; 6(7):e22114. PubMed ID: 21799775
[TBL] [Abstract][Full Text] [Related]
37. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.
Takeda K; Kinoshita I; Shimizu Y; Matsuno Y; Shichinohe T; Dosaka-Akita H
Anticancer Res; 2011 Jan; 31(1):263-70. PubMed ID: 21273608
[TBL] [Abstract][Full Text] [Related]
38. Accelerated perineural invasion in colitis-associated cancer: A retrospective cohort study.
Nozawa H; Hata K; Ushiku T; Kawai K; Tanaka T; Shuno Y; Nishikawa T; Sasaki K; Emoto S; Kaneko M; Murono K; Sonoda H; Ishihara S
Medicine (Baltimore); 2019 Oct; 98(42):e17570. PubMed ID: 31626124
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer.
Yuza K; Nagahashi M; Shimada Y; Nakano M; Tajima Y; Kameyama H; Nakajima M; Takabe K; Wakai T
J Surg Res; 2018 Nov; 231():323-330. PubMed ID: 30278948
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.
Hsu HC; Liu YS; Tseng KC; Hsu CL; Liang Y; Yang TS; Chen JS; Tang RP; Chen SJ; Chen HC
Int J Colorectal Dis; 2013 Nov; 28(11):1535-46. PubMed ID: 23784051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
